The role of collagen antibodies in mediating arthritis

References

• Mackay IR, Burnet FM. Autoimmune diseases. Pathogenesis, chemistry and therapy. New York: Charles C Thomas; 1963.
   Google Scholar
• Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM 3rd, Therneau TM, et al. The widening mortality gap between rheumatoid arthritis patients and the general popula-tion. Arthritis Rheum. 2007;56:3583–7.
   Google Scholar
• Landewe R, Geusens P, Boers M, van der Heijde D, Lems W, te Koppele J, et al. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radio-graphic progression in patients with rheumatoid arthritis. Arthritis Rheum. 2004;50:1390–9.
   Google Scholar
• van der Pouw Kraan T, Wijbrandts C, van Baarsen L, Rusten-burg F, Bagge J, Verweij C, et al. Responsiveness to anti-TNF alpha therapy is related to pre-treatment tissue inflammation levels in rheumatoid arthritis patients. Ann Rheum Dis. 2008;67(4):563–6.
   Google Scholar
• Edwards JC, Cambridge G. Sustained improvement in rheuma-toid arthritis following a protocol designed to deplete B lymphocytes. Rheumatology (Oxford). 2001;40:205–11.
   PubMed Web of Science ®Google Scholar
• Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sos-nowska A, Emery P, Close DR, et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med. 2004;350:2572–81.
   Google Scholar
• Smolen JS, Keystone EC, Emery P, Breedveld FC, Betteridge N, Burmester GR, et al. Consensus statement on the use of ritux-imab in patients with rheumatoid arthritis. Ann Rheum Dis. 2007;66:143–50.
   PubMed Web of Science ®Google Scholar
• Edwards JC, Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol. 2006;6:394–403.
   PubMed Web of Science ®Google Scholar
• van Venrooij WJ, Zendman AJ, Pruijn GJ. Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. Autoimmun Rev. 2006;6:37–41.
   Google Scholar
• Mimori T. Clinical significance of anti-CCP antibodies in rheumatoid arthritis. Intern Med. 2005;44:1122–6.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Yamada R, Yamamoto K. Citrullination by peptidy-larginine deiminase in rheumatoid arthritis. Ann NY Acad Sci. 2007;1108:323–39.
   PubMed Web of Science ®Google Scholar
• Nandakumar KS, Bajtner E, Hill L, Bohm B, Rowley MJ, Burkhardt H, et al. Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize car-tilage independent of inflammation. Arthritis Rheum. 2007;58:184–96.
   Google Scholar
• Steffen C. Consideration of pathogenesis of rheumatoid arthritis as collagen autoimmunity. Z Immunitatsforsch Allerg Klin Immunol. 1970;139:219–27.
   Google Scholar
• Miller EJ, Matukas VJ. Chick cartilage collagen: a new type of alpha 1 chain not present in bone or skin of the species. Proc Natl Acad Sci USA. 1969;64:1264–8.
   PubMed Web of Science ®Google Scholar
• Cook AD, Rowley MJ, Stockman A, Muirden KD, Mackay IR. Specificity of antibodies to type II collagen in early rheumatoid arthritis. J Rheumatol. 1994;21:1186–91.
   Google Scholar
• Cook AD, Gray R, Ramshaw J, Mackay IR, Rowley MJ. Anti-bodies against the CB10 fragment of type II collagen in rheumatoid arthritis. Arthritis Res Ther. 2004;6:R477–83.
   Google Scholar
• Ronnelid J, Lysholm J, Engstrom-Laurent A, Klareskog L, Heyman B. Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum. 1994;37: 1023–9.
   Google Scholar
• Londei M, Savill CM, Verhoef A, Brennan F, Leech ZA, Du-ance V, et al. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc Natl Acad Sci USA. 1989;86:636–40.
   Google Scholar
• Kinne RW, Palombo-Kinne E, Emmrich F. T-cells in the path-ogenesis of rheumatoid arthritis villains or accomplices? Biochim Biophys Acta. 1997;1360:109-41.
   Google Scholar
• Berg L, Ronnelid J, Sanjeevi CB, Lampa J, Klareskog L. Inter-feron-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Arthritis Res. 2000;2: 75–84.
   Google Scholar
• Ohnishi Y, Tsutsumi A, Sakamaki T, Sumida T. T cell epitopes of type II collagen in HLA-DRB1*0101 or DRB1*0405-positive Japanese patients with rheumatoid arthritis. Int J Mol Med. 2003;11:331–5.
   PubMed Web of Science ®Google Scholar
• Jaalinoja J, Nissila M, Kauppi M, Hakala M, Laiho K, Karttunen R, et al. Serum antibodies against intact human collagen IX are elevated at the onset of RA but are not related to the develop-ment of erosions. J Rheumatol. 2008.
   Google Scholar
• Pereira RS, Black CM, Duance VC, Jones VE, Jacoby RK, Welsh KT. Disappearing collagen antibodies in rheumatoid arthritis. Lancet. 1985;2:501–2.
   PubMedGoogle Scholar
• Fujii K, Tsuji M, Kitamura A, Murota K. The diagnostic sig-nificance of anti-type II collagen antibody assay in rheumatoid arthritis. Int Orthop. 1992;16:272–6.
   PubMedGoogle Scholar
• Cook AD, Rowley MJ, Mackay IR, Gough A, Emery P. Anti-bodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum. 1996;39:1720–7.
   Google Scholar
• Cook AD, Stockman A, Brand CA, Tait BD, Mackay IR, Mu-irden KD, Bernard CC, Rowley MJ. Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis. Arthritis Rheum. 1999;42:2569–76.
   PubMedGoogle Scholar
• Witebsky E, Rose NR, Terplan K, Paine JR, Egan RW. Chronic thyroiditis and autoimmunization. J Am Med Assoc. 1957;164:1439–47.
   PubMed Web of Science ®Google Scholar
• Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 1980;283:666–8.
   Google Scholar
• Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 1977;146:857–68.
   Google Scholar
• Cathcart ES, Hayes KC, Gonnerman WA, Lazzari AA, Fran-zblau C. Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen. Lab Invest. 1986;54:26–31.
   Google Scholar
• Wernhoff P, Unger C, Bajtner E, Burkhardt H, Holmdahl R. Identification of conformation-dependent epitopes and V gene selection in the B cell response to type II collagen in the DA rat. Int Immunol. 2001;13:909–19.
   Google Scholar
• Kraetsch HG, Unger C, Wernhoff P, Schneider C, Kalden JR, Holmdahl R, et al. Cartilage-specific autoimmunity in rheuma-toid arthritis: characterization of a triple helical B cell epitope in the integrin-binding-domain of collagen type II. Eur J Immunol. 2001;31:1666–73.
   Google Scholar
• Burkhardt H, Koller T, Engstrom A, Nandakumar KS, Tumay J, Kraetsch HG, et al. Epitope-specific recognition of type II colla-gen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum. 2002;46:2339–48.
   PubMed Web of Science ®Google Scholar
• von Delwig A, Altmann DM, Charlton FG, McKie N, Isaacs JD, Holmdahl R, et al. T cell responses to a non-glycosylated epi-tope predominate in type II collagen-immunised HLA-DRB1*0101 transgenic mice. Ann Rheum Dis. 2007;66:599–604.
   PubMed Web of Science ®Google Scholar
• Dzhambazov B, Holmdahl M, Yamada H, Lu S, Vestberg M, Holm B, et al. The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans. Eur J Immunol. 2005;35:357–66.
   PubMed Web of Science ®Google Scholar
• Brunsberg U, Gustafsson K, Jansson L, Michaelsson E, Ahrl-und-Richter L, Pettersson S, et al. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol. 1994;24:1698–702.
   Google Scholar
• Myers LK, Rosloniec EF, Cremer MA, Kang AH. Collagen-induced arthritis, an animal model of autoimmunity. Life Sci. 1997;61:1861–78.
   PubMed Web of Science ®Google Scholar
• Cremer MA, Rosloniec EF, Kong AH. The cartilage collagens: a review of their structure, organization, and role in the patho-genesis of experimental arthritis in animals and in human rheumatic disease. J Mol Med. 1998;76:275–88.
   Google Scholar
• Luross JA, Williams NA. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology. 2001;103:407–16.
   PubMed Web of Science ®Google Scholar
• Nandakumar KS, Holmdahl R. Antibody-induced arthritis: dis-ease mechanisms and genes involved at the effector phase of arthritis. Arthritis Res Ther. 2006;8:223.
   PubMedGoogle Scholar
• Holmdahl R, Jansson L, Gullberg D, Rubin K, Forsberg PO, Klareskog L. Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II. Clin Exp Immunol. 1985;62:639–46.
   PubMed Web of Science ®Google Scholar
• Holmdahl R, Jansson L, Larsson E, Rubin K, Klareskog L. Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum. 1986;29:106–13.
   PubMed Web of Science ®Google Scholar
• Nabozny GH, Baisch JM, Cheng S, Cosgrove D, Griffiths MM, Luthra HS, et al. HLA-DQ8 transgenic mice are highly sus-ceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med. 1996;183:27–37.
   PubMed Web of Science ®Google Scholar
• Rosloniec EF, Brand DD, Myers LK, Whittington KB, Guma-novskaya M, Zaller DM, et al. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med. 1997;185: 1113–22.
   Google Scholar
• Andersson EC, Hansen BE, Jacobsen H, Madsen LS, Andersen CB, Engberg J, et al. Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proc Natl Acad Sci USA. 1998;95:7574–9.
   PubMed Web of Science ®Google Scholar
• Backlund J, Carlsen S, Hoger T, Holm B, Fugger L, Kihlberg J, et al. Predominant selection of T cells specific for the glycos-ylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci USA. 2002;99:9960–5.
   PubMed Web of Science ®Google Scholar
• Corthay A, Backlund J, Broddefalk J, Michaelsson E, Golds-chmidt TJ, Kihlberg J, et al. Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur J Immunol. 1998;28:2580–90.
   Google Scholar
• Backlund J, Treschow A, Bockermann R, Holm B, Holm L, Issazadeh-Navikas S, et al. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in col-lagen-induced arthritis. Eur J Immunol. 2002;32:3776–84.
   Google Scholar
• Holmdahl R. Genetics of susceptibility to chronic experimental encephalomyelitis and arthritis. Curr Opin Immunol. 1998;10:710-7. arthritis predicts a common framework of cross-species infiammatory/autoimmune disease loci. Immunol Rev. 2001;184: 172–83.
   Google Scholar
• Bergsteinsdottir K, Yang HT, Pettersson U, Holmdahl R. Evi-dence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis. J Immunol. 2000;164:1564–8.
   PubMed Web of Science ®Google Scholar
• Andersson A, Holmdahl R. A genetic basis for shared autoim-munity in mouse models. Autoimmunity. 2005;38:209–17.
   PubMed Web of Science ®Google Scholar
• Corthay A, Johansson A, Vestberg M, Holmdahl R. Collagen-induced arthritis development requires alpha beta T cells but not gamma delta T cells: studies with T cell-deficient (TCR mutant) mice. Int Immunol. 1999;11:1065–73.
   PubMed Web of Science ®Google Scholar
• Svensson L, Jirholt J, Holmdahl R, Jansson L. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin Exp Immunol. 1998;111:521–6.
   PubMedGoogle Scholar
• Seki N, Sudo Y, Yoshioka T, Sugihara S, Fujitsu T, Sakuma S, et al. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. J Immunol. 1988;140:1477–84.
   Google Scholar
• Holmdahl R, Andersson M, Goldschmidt TJ, Gustafsson K, Jansson L, Mo JA. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev. 1990;118:193–232.
   PubMed Web of Science ®Google Scholar
• Terato K, Hasty KA, Reife RA, Cremer MA, Kang AH, Stuart JM. Induction of arthritis with monoclonal antibodies to colla-gen. J Immunol. 1992;148:2103–8.
   PubMed Web of Science ®Google Scholar
• Mo JA, Scheynius A, Nilsson S, Holmdahl R. Germline-enco-ded IgG antibodies bind mouse cartilage in vivo: epitope- and idiotype-specific binding and inhibition. Scand J Immunol. 1994;39:122–30.
   Google Scholar
• Schulte S, Unger C, Mo JA, Wendler 0, Bauer E, Frischholz S, et al. Arthritis-related B cell epitopes in collagen II are con-formation-dependent and sterically privileged in accessible sites of cartilage collagen fibrils. J Biol Chem. 1998;273:1551–61.
   Google Scholar
• Bajtner E, Nandakumar KS, Engstrom A, Holmdahl R. Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen. Arthritis Res 'Ther. 2005;7:R1148–57.
   PubMedGoogle Scholar
• Holmdahl R, Bailey C, Enander I, Mayer R, Klareskog L, Moran T, et al. Origin of the autoreactive anti-type II collagen response. II. Specificities, antibody isotypes and usage of V gene families of anti-type II collagen B cells. J Immunol. 1989;142:1881–6.
   Google Scholar
• Michaelsson E, Andersson M, Engstrom A, Holmdahl R. Iden-tification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur J Immunol. 1992;22:1819–25.
   PubMed Web of Science ®Google Scholar
• Griffiths MM, Remmers EF. Genetic analysis of induced arthritis arthritis in rats: a polygenic model for rheumatoid EF. Genetic analysis of collagen-a polygenic model for rheumatoid
   Google Scholar
• Michaelsson E, Malmstrom V, Reis S, Engstrom A, Burkhardt H, Holmdahl R. T cell recogition of carbohydrates on type II collagen. J Exp Med. 1994;180:745–9.
   PubMed Web of Science ®Google Scholar
• Stuart JM, Cremer MA, Townes AS, Kong AH. Type II colla-gen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med. 1982;155:1–16.
   Google Scholar
• Stuart JM, Dixon FJ. Serum transfer of collagen-induced arthritis in mice. J Exp Med. 1983;158:378–92.
   PubMed Web of Science ®Google Scholar
• Holmdahl R, Rubin K, Klareskog L, Larsson E, Wigzell H. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II colla-gen antibodies. Arthritis Rheum. 1986;29:400–10.
   Google Scholar
• Nandakumar KS, Andren M, Martinsson P, Bajtner E, Hellstrom S, Holmdahl R, et al. Induction of arthritis by single monoclonal IgG anti-collagen type II antibodies and enhancement of arthritis in mice lacking inhibitory FcgammaRIIB. Eur J Immunol. 2003;33:2269–77.
   PubMed Web of Science ®Google Scholar
• Nandakumar KS, Svensson L, Holmdahl R. Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol. 2003;163:1827–37.
   Google Scholar
• Wooley PH, Luthra HS, Singh SK, Huse AR, Stuart JM, David CS. Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc. 1984;59:737–43.
   PubMedGoogle Scholar
• Petkova SB, Konstantinov KN, Sproule TJ, Lyons BL, Awwami MA, Roopenian DC. Human antibodies induce arthritis in mice deficient in the low-affinity inhibitory IgG receptor Fc gamma RIB. J Exp Med. 2006;203:275–80.
   PubMed Web of Science ®Google Scholar
• Terato K, Harper DS, Griffiths MM, Hasty DL, Ye XJ, Cremer MA, et al. Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity. 1995;22:137–47.
   Google Scholar
• Nandakumar KS, Holmdahl R. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal anti-bodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis. J Immunol Methods. 2005;304:126–36.
   PubMedGoogle Scholar
• Nandakumar KS, Johansson BP, Bjorck L, Holmdahl R. Blocking of experimental arthritis by cleavage of IgG antibodies in vivo. Arthritis Rheum. 2007;56:3253–60.
   PubMed Web of Science ®Google Scholar
• Morgan K, Clague RB, Shaw MJ, Firth SA, Twose TM, Holt PJ. Native type II collagen-induced arthritis in the rat: the effect of complement depletion by cobra venom factor. Arthritis Rheum. 1981;24:1356–62.
   PubMed Web of Science ®Google Scholar
• Watson WC, Townes AS. Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J Exp Med. 1985;162: 1878–91.
   Google Scholar
• Spinella DG, Jeffers JR, Reife RA, Stuart JM. The role of C5 and T-cell receptor Vb genes in susceptibility to collagen-induced arthritis. Immunogenetics. 1991;34:23–7.
   PubMedGoogle Scholar
• Hietala MA, Jonsson IM, Tarkowski A, Kleinau S, Pekna M. Complement deficiency ameliorates collagen-induced arthritis in mice. J Immunol. 2002;169:454–9.
   Google Scholar
• Hietala MA, Nandakumar KS, Persson L, Fahlen S, Holmdahl R, Pekna M. Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis. Eur J Immunol. 2004;34:1208–16.
   PubMed Web of Science ®Google Scholar
• Banda NK, Takahashi K, Wood AK, Holers VM, Arend WP. Pathogenic complement activation in collagen antibody-induced arthritis in mice requires amplification by the alternative path-way. J Immunol. 2007;179:4101–9.
   Google Scholar
• Kagari T, Tanaka D, Doi H, Shimozato T. Essential role of Fc gamma receptors in anti-type II collagen antibody-induced arthritis. J Immunol. 2003;170:4318–24.
   PubMed Web of Science ®Google Scholar
• Dijstelbloem HM, Hip M, Fijnheer R, Scheepers RH, Oost WW, Jansen MD, et al. Fcgamma receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes. Arthritis Rheum. 2000;43: 2793–800.
   PubMedGoogle Scholar
• Takai T. Roles of Fc receptors in autoimmunity. Nat Rev Immunol. 2002;2:580–92.
   PubMed Web of Science ®Google Scholar
• Tan Sardjono C, Mottram PL, van de Velde NC, Powell MS, Power D, Slocombe RF, et al. Development of spontaneous multisystem autoimmune disease and hypersensitivity to anti-body-induced inflammation in Fcgamma receptor Ha-transgenic mice. Arthritis Rheum. 2005;52:3220–9.
   Google Scholar
• Nabbe KC, Blom AB, Holthuysen AE, Boross P, Roth J, Verbeek S, et al. Coordinate expression of activating Fc gamma receptors I and III and inhibiting Fc gamma receptor type II in the determination of joint inflammation and cartilage destruction during immune complex-mediated arthritis. Arthritis Rheum. 2003;48:255–65.
   Google Scholar
• Matsumoto I, Maccioni M, Lee DM, Maurice M, Simmons B, Brenner M, et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol. 2002;3:360–5.
   PubMed Web of Science ®Google Scholar
• Nandakumar KS, Backlund J, Vestberg M, Holmdahl R. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CH-reactive T cells. Arthritis Res 'Ther. 2004;6:R544–50.
   Web of Science ®Google Scholar
• Santos LL, Milenkovski GP, Hall PH, Leech M, Sharma L, Takeda K, et al. IL-18 is redundant in T-cell responses and in joint inflammation in antigen-induced arthritis. Immunol Cell Biol. 2006;84:166–73.
   Google Scholar
• Hogarth PM. Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr Opin Immunol. 2002;14:798–802.
   PubMed Web of Science ®Google Scholar
• Amigorena S, Bonnerot C. Fc receptor signaling and trafficking: a connection for antigen processing. Immunol Rev. 1999;172:279–84.
   PubMed Web of Science ®Google Scholar
• Kagari T, Doi H, Shimozato T. The importance of IL-1 beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J Immunol. 2002;169: 1459–66.
   Google Scholar
• Nandakumar KS, Holmdahl R. Arthritis induced with cartilage-specific antibodies is IL-4-dependent. Eur J Immunol. 2006;36:1608–18.
   Google Scholar
• Tanaka D, Kagari T, Doi H, Shimozato T. Essential role of neutrophils in anti-type II collagen antibody and lipopolysac-charide-induced arthritis. Immunology. 2006;119:195–202.
   PubMed Web of Science ®Google Scholar
• Thou JS, Xing W, Friend DS, Austen KF, Katz HR. Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis. J Exp Med. 2007;204:2797–802.
   Google Scholar
• Johansson AC, Hansson AS, Nandakumar KS, Backlund J, Holmdahl R. IL-10-deficient B10.Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies. J Immunol. 2001;167: 3505–12.
   Google Scholar
• Svensson L, Nandakumar KS, Johansson A, Jansson L, Holm-dahl R. IL-4-deficient mice develop less acute but more chronic relapsing collagen-induced arthritis. Eur J Immunol. 2002;32: 2944–53.
   Google Scholar
• Treschow AP, Teige I, Nandakumar KS, Holmdahl R, Issa-zadeh-Navikas S. Stromal cells and osteoclasts are responsible for exacerbated collagen-induced arthritis in interferon-beta-deficient mice. Arthritis Rheum. 2005;52:3739–48.
   Google Scholar
• Sakuma M, Hatsushika K, Koyama K, Katoh R, Ando T, Wa-tanabe Y, et al. TGF-beta type I receptor kinase inhibitor down-regulates rheumatoid synoviocytes and prevents the arthritis induced by type II collagen antibody. Int Immunol. 2007;19:117–26.
   Google Scholar
• Jasin HE. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 1985;28:241–8.
   PubMed Web of Science ®Google Scholar
• Mathsson L, Lampa J, Mullazehi M, Ronnelid J. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRlla dependent and rheumatoid factor correlated pro-duction of tumour necrosis factor-alpha by peripheral blood mononuclear cells. Arthritis Res Ther. 2006;8:R64.
   Google Scholar
• Mullazehi M, Mathsson L, Lampa J, Ronnelid J. Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor alpha, interleukin-lbeta, interleukin-8 from peripheral blood monocytes via Fc gamma receptor IIA: a potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis. Arthritis Rheum. 2006;54:1759–71.
   Google Scholar
• Mullazehi M, Mathsson L, Lampa J, Ronnelid J. High anti-collagen type-II antibody levels and induction of proinflamma-tory cytokines by anti-collagen antibody-containing immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the time of disease onset. Ann Rheum Dis. 2007;66:537–41.
   PubMed Web of Science ®Google Scholar
• Reife RA, Loutis N, Watson WC, Hasty KA, Stuart JM. SWR mice are resistant to collagen-induced arthritis but produce potentially arthritogenic antibodies. Arthritis Rheum. 1991;34: 776–81.
   Google Scholar
• Wooley PH, Chapedelaine JM. Immunogenetics of collagen-induced arthritis. Crit Rev Immunol. 1987;8:1–22.
   PubMed Web of Science ®Google Scholar
• Brand DD, Marion TN, Myers LK, Rosloniec EF, Watson WC, Stuart JM, et al. Autoantibodies to murine type II collagen in collagen-induced arthritis: a comparison of susceptible and nonsusceptible strains. J Immunol. 1996;157:5178–84.
   Google Scholar
• Crombie DE, Turer M, Zuasti BB, Wood B, McNaughton D, Nandakumar KS, et al. Destructive effects of murine arthrito-genic antibodies to type II collagen on cartilage explants in vitro. Arthritis Res Ther. 2005;7:R927–37.
   PubMed Web of Science ®Google Scholar
• Amirahmadi SF, Whittingham S, Crombie DE, Nandakumar KS, Holmdahl R, Mackay IR, et al. Arthritogenic anti-type II collagen antibodies are pathogenic for cartilage-derived chon-drocytes independent of inflammatory cells. Arthritis Rheum. 2005;52:1897–906.
   Google Scholar
• Amirahmadi SF, Pho MH, Gray RE, Crombie DE, Whittingham SF, Zuasti BB, et al. An arthritogenic monoclonal antibody to type II collagen, Cl-Cl, impairs cartilage formation by cultured chondrocytes. Immunol Cell Biol. 2004;82:427–34.
   PubMed Web of Science ®Google Scholar
• Mansson B, Wenglen C, Morgelin M, Saxne T, Heinegard D. Association of chondroadherin with collagen type II. J Biol Chem. 2001;276:32883–8.
   Google Scholar
• Fertala A, Sieron AL, Adachi E, Jimenez SA. Collagen II con-taining a Cys substitution for Arg-alphal-519: abnormal interactions of the mutated molecules with collagen IX. Bio-chemistry. 2001;40:14422–8.
   Google Scholar
• Mallein-Gerin F, Ruggiero F, Quinn TM, Bard F, Grodzinsky AJ, Olsen BR, et al. Analysis of collagen synthesis and assembly in culture by immortalized mouse chondrocytes in the presence or absence of alpha 1(IX) collagen chains. Exp Cell Res. 1995;219: 257–65.
   Google Scholar
• Nakata K, Ono K, Miyazaki J, Olsen BR, Muragaki Y, Adachi E, et al. Osteoarthritis associated with mild chondrodysplasia in transgenic mice expressing alpha 1(IX) collagen chains with a central deletion. Proc Natl Acad Sci USA. 1993;90:2870–4.
   PubMed Web of Science ®Google Scholar
• Fassler R, Schnegelsberg PN, Dausman J, Shinya T, Muragaki Y, McCarthy MT, et al. Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease. Proc Natl Acad Sci USA. 1994;91:5070–4.
   PubMed Web of Science ®Google Scholar
• Briggs MD, Choi H, Warman ML, Loughlin JA, Wordsworth P, Sykes BC, et al. Genetic mapping of a locus for multiple epiph-yseal dysplasia (EDM2) to a region of chromosome 1 containing a type IX collagen gene. Am J Hum Genet. 1994;55:678–84.
   PubMedGoogle Scholar
• Muragaki Y, Mariman EC, van Beersum SE, Perala M, van Mourik JB, Warman ML, et al. A mutation in COL9A2 causes multiple epiphyseal dysplasia (EDM2). Ann N Y Acad Sci. 1996;785:303–6.
   Google Scholar
• Carlsen S, Nandakumar KS, Holmdahl R. Type IX collagen deficiency enhances the binding of cartilage-specific antibodies and arthritis severity. Arthritis Res Ther. 2006;8:R102.
   Google Scholar
• Knight CG, Morton LF, Peachey AR, Tuckwell DS, Farndale RW, Barnes MJ. The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) col-lagens. J Biol Chem. 2000;275:35–40.
   PubMed Web of Science ®Google Scholar
• Siljander PR, Hamaia S, Peachey AR, Slatter DA, Smethurst PA, Ouwehand WH, et al. Integrin activation state determines selectivity for novel recognition sites in fibrillar collagens. J Biol Chem. 2004;279:47763–72.
   PubMed Web of Science ®Google Scholar
• Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285:1028–32.
   PubMed Web of Science ®Google Scholar
• Pulai JI, Del Carlo M Jr, Loeser RF. The alpha5betal integrin provides matrix survival signals for normal and osteoarthritic human articular chondrocytes in vitro. Arthritis Rheum. 2002;46:1528–35.
   PubMed Web of Science ®Google Scholar
• Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, et al. Matrix metalloproteinases and tissue inhibi-tors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis. 2000;59:455–61.
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Naito S, Enomoto H, Shiomoi T, Kimura T, Obata K, et al. Serum levels of matrix metalloproteinase 3 (stromelysin 1) for monitoring synovitis in rheumatoid arthritis. Arch Pathol Lab Med. 2007;131:563–70.
   PubMed Web of Science ®Google Scholar
• Wu JJ, Lark MW, Chun LE, Eyre DR. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem. 1991;266:5625–8.
   PubMed Web of Science ®Google Scholar
• Tiku K, Thakker-Varia S, Ramachandrula A, Tiku ML. Artic-ular chondrocytes secrete IL-1, express membrane IL-1, and have IL-1 inhibitory activity. Cell Immunol. 1992;140:1–20.
   PubMedGoogle Scholar
• Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum. 2001;44:585–94.
   Google Scholar
• Pap T, van der Laan WH, Aupperle KR, Gay RE, Verheijen JH, Firestein GS, et al. Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis. Arthritis Rheum. 2000;43:2531–6.
   PubMed Web of Science ®Google Scholar
• Waaler E. On the occurrence of a factor in human serum acti-vating the specific agglutination of sheep blood corpuscles. Acta Pathol Microbiol Scand. 1940;17:172.
   Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Erlandsson Harris H, Liljestrom M, Klareskog L. Characteristics of synovial fluid effusion in collagen-induced arthritis (CIA) in the DA rat; a comparison of histology and antibody reactivities in an experimental chronic arthritis model and rheumatoid arthritis (RA). Clin Exp Immunol. 1997;107:480–4.
   Google Scholar
• Klareskog L. What can we learn about rheumatoid arthritis from animal models? Springer Semin Immunopathol. 1989;11:315–33.
   Google Scholar
• Tarkowski A, Holmdahl R, Klareskog L. Rheumatoid factors in mice. Monogr Allergy. 1989;26:214–29.
   PubMedGoogle Scholar
• Holmdahl R, Nordling C, Rubin K, Tarkowski A, Klareskog L. Generation of monoclonal rheumatoid factors after immuniza-tion with collagen II-anti-collagen II immune complexes. An anti-idiotypic antibody to anti-collagen II is also a rheumatoid factor. Scand J Immunol. 1986;24:197–203.
   Google Scholar
• Taneja V, Taneja N, Paisansinsup T, Behrens M, Griffiths M, Luthra H, et al. CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis. J Immunol. 2002;168:5867–75.
   PubMed Web of Science ®Google Scholar
• Quinones MP, Ahuja SK, Jimenez F, Schaefer J, Garavito E, Rao A, et al. Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis. J Clin Invest. 2004;113:856–66.
   PubMed Web of Science ®Google Scholar
• Uysal H, Sehnert B, Nandakumar KS, Boiers U, Burkhardt H, Holmdahl R, et al. The crystal structure of the pathogenic col-lagen type II-specific mouse monoclonal antibody CIIC1 Fab: Structure to function analysis. Mol Immunol. 2008;45:2196–204.
   Google Scholar
• Williams RC Jr Hypothesis: rheumatoid factors are antiidiotypes related to bacterial or viral Fc receptors. Arthritis Rheum. 1988;31:1204–7.
   Google Scholar
• Nowak UM, Newkirk MM. Rheumatoid factors: good or bad for you? Int Arch Allergy Immunol. 2005;138:180-8.
   Google Scholar
• Aho K, Konttinen A, Rajasalmi M, Wager 0. Transient appearance of the rheumatoid factor in connection with pro-phylactic vaccinations. Acta Pathol Microbiol Scand. 1962;56:478–9.
   Google Scholar
• Carson DA, Chen PP, Fox RI, Kipps TJ, Jirik F, Goldfien RD, et al. Rheumatoid factor and immune networks. Annu Rev Immunol. 1987;5:109–26.
   PubMed Web of Science ®Google Scholar
• Fehr T, Bachmann MF, Bucher E, Kalinke U, Di Padova FE, Lang AB, et al. Role of repetitive antigen patterns for induction of antibodies against antibodies. J Exp Med. 1997;185:1785–92.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Tsuji M, Kurosaka D, Yasuda J, Ito Y, Nishizawa T, et al. Autoimmunity to citrullinated type II collagen in rheu-matoid arthritis. Mod Rheumatol. 2006;16:276–81.
   PubMedGoogle Scholar
• Burkhardt H, Sehnert B, Bockermann R, Engstrom A, Kalden JR, Holmdahl R. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis. Eur J Immunol. 2005;35:1643–52.
   PubMed Web of Science ®Google Scholar
• Yamada R, Suzuki A, Chang X, Yamamoto K. Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-sus-ceptible gene. Trends Mol Med. 2003;9:503–8.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, et al. Functional haplotypes of PADI4, encoding citrulli-nating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet. 2003;34:395–402.
   PubMed Web of Science ®Google Scholar
• Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest. 2006;116:961–73.
   PubMed Web of Science ®Google Scholar
• Weyand C, Goronzy J. Pathomechanisms in rheumatoid arthri-tis-time for a string theory? J Clin Invest. 2006;116:869–71.
   Google Scholar
• Konttinen YT, Li TF, Lassus J, Waris V, Santavirta S, Virtanen I. Removal of hyaline articular cartilage reduces lymphocyte infiltration and activation in rheumatoid synovial membrane. J Rheumatol. 2001;28:2184–9.
   Google Scholar